Similar articles

• Structural requirements of platelet chemokines for neutrophil activation.

  Yan Z, Zhang J, Holt JC, Stewart GJ, Niewiarowski S, Poncz M. Yan Z, et al. Blood. 1994 Oct 1;84(7):2329-39. Blood. 1994. PMID: 7919350
• The neutrophil-activating peptide 1/interleukin 8, a novel neutrophil chemotactic cytokine.

  Schröder JM. Schröder JM. Arch Immunol Ther Exp (Warsz). 1992;40(1):23-31. Arch Immunol Ther Exp (Warsz). 1992. PMID: 1485824 Review. No abstract available.
• Formation and biological properties of neutrophil activating peptide 2 (NAP-2).

  Walz A, Zwahlen R, Baggiolini M. Walz A, et al. Adv Exp Med Biol. 1991;305:39-46. doi: 10.1007/978-1-4684-6009-4_5. Adv Exp Med Biol. 1991. PMID: 1755378 Review. No abstract available.
• Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.

  Piccardoni P, Evangelista V, Piccoli A, de Gaetano G, Walz A, Cerletti C. Piccardoni P, et al. Thromb Haemost. 1996 Nov;76(5):780-5. Thromb Haemost. 1996. PMID: 8950790
• Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors.

  Zipfel PF, Balke J, Irving SG, Kelly K, Siebenlist U. Zipfel PF, et al. J Immunol. 1989 Mar 1;142(5):1582-90. J Immunol. 1989. PMID: 2521882